These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 34410557)

  • 1. Performance of Multiple-Batch Approaches to Pharmacokinetic Bioequivalence Testing for Orally Inhaled Drug Products with Batch-to-Batch Variability.
    Burmeister Getz E; Carroll KJ; Christopher JD; Morgan B; Haughie S; Cavecchi A; Wiggenhorn C; Beresford H; Strickland H; Lyapustina S
    AAPS PharmSciTech; 2021 Aug; 22(7):225. PubMed ID: 34410557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Batch Selection via In Vitro/In Vivo Correlation in Pharmacokinetic Bioequivalence Testing.
    Burmeister Getz E; Carroll KJ; Mielke J; Jones B; Benet LZ
    AAPS PharmSciTech; 2021 Aug; 22(7):224. PubMed ID: 34410534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of the Population Bioequivalence (PBE) Statistical Test with Impactor Sized Mass Data.
    Chen S; Morgan B; Beresford H; Burmeister Getz E; Christopher D; Långström G; Strickland H; Wiggenhorn C; Lyapustina S
    AAPS PharmSciTech; 2019 Aug; 20(7):296. PubMed ID: 31444601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Batch-to-batch pharmacokinetic variability confounds current bioequivalence regulations: A dry powder inhaler randomized clinical trial.
    Burmeister Getz E; Carroll KJ; Jones B; Benet LZ
    Clin Pharmacol Ther; 2016 Sep; 100(3):223-31. PubMed ID: 27037630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Between-Batch Bioequivalence (BBE): a Statistical Test to Evaluate In Vitro Bioequivalence Considering the Between-Batch Variability.
    Bodin J; Liandrat S; Kocevar G; Petitcolas C
    AAPS J; 2020 Sep; 22(5):119. PubMed ID: 32910283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Between-Batch Pharmacokinetic Variability Inflates Type I Error Rate in Conventional Bioequivalence Trials: A Randomized Advair Diskus Clinical Trial.
    Burmeister Getz E; Carroll KJ; Mielke J; Benet LZ; Jones B
    Clin Pharmacol Ther; 2017 Mar; 101(3):331-340. PubMed ID: 27727445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioequivalence assessment of pharmaceutical aerosol products through IVIVC.
    Sandell D
    Adv Drug Deliv Rev; 2021 Sep; 176():113895. PubMed ID: 34329687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of the Population Bioequivalence (PBE) Statistical Test Using an IPAC-RS Database of Delivered Dose from Metered Dose Inhalers.
    Morgan B; Chen S; Christopher D; Långström G; Wiggenhorn C; Burmeister Getz E; Beresford H; Hoffelder T; Acerbi D; Andrews S; Berry M; Dey M; Joshi K; McKenry M; Pertile M; Strickland H; Wilcox D; Lyapustina S
    AAPS PharmSciTech; 2018 Apr; 19(3):1410-1425. PubMed ID: 29435904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Model-based bioequivalence approach for sparse pharmacokinetic bioequivalence studies: Model selection or model averaging?
    Philipp M; Tessier A; Donnelly M; Fang L; Feng K; Zhao L; Grosser S; Sun G; Sun W; Mentré F; Bertrand J
    Stat Med; 2024 Aug; 43(18):3403-3416. PubMed ID: 38847215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of Orally Inhaled Drug Products.
    Hochhaus G; Horhota S; Hendeles L; Suarez S; Rebello J
    AAPS J; 2015 May; 17(3):769-75. PubMed ID: 25762449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generic lamotrigine versus brand-name Lamictal bioequivalence in patients with epilepsy: A field test of the FDA bioequivalence standard.
    Ting TY; Jiang W; Lionberger R; Wong J; Jones JW; Kane MA; Krumholz A; Temple R; Polli JE
    Epilepsia; 2015 Sep; 56(9):1415-24. PubMed ID: 26201987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple testing for bioequivalence with pharmacokinetic data in 2 x 2 crossover designs.
    Chen YI; Huang CS
    Stat Med; 2009 Dec; 28(28):3567-79. PubMed ID: 19760611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of pharmacokinetics in establishing bioequivalence for orally inhaled drug products: workshop summary report.
    O'Connor D; Adams WP; Chen ML; Daley-Yates P; Davis J; Derendorf H; Ducharme MP; Fuglsang A; Herrle M; Hochhaus G; Holmes SM; Lee SL; Li BV; Lyapustina S; Newman S; Oliver M; Patterson B; Peart J; Poochikian G; Roy P; Shah T; Singh GJ; Sharp SS
    J Aerosol Med Pulm Drug Deliv; 2011 Jun; 24(3):119-35. PubMed ID: 21453049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The bioequivalence of highly variable drugs and drug products.
    Midha KK; Rawson MJ; Hubbard JW
    Int J Clin Pharmacol Ther; 2005 Oct; 43(10):485-98. PubMed ID: 16240706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioequivalence between innovator and generic tacrolimus in liver and kidney transplant recipients: A randomized, crossover clinical trial.
    Alloway RR; Vinks AA; Fukuda T; Mizuno T; King EC; Zou Y; Jiang W; Woodle ES; Tremblay S; Klawitter J; Klawitter J; Christians U
    PLoS Med; 2017 Nov; 14(11):e1002428. PubMed ID: 29135993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drilling down the bioequivalence assessment of topical antifungal products: Microstructure and release.
    Miranda M; Cardoso C; Pais AACC; Brown M; Vitorino C
    Eur J Pharm Biopharm; 2023 Apr; 185():94-106. PubMed ID: 36806630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. International Guidelines for Bioequivalence of Locally Acting Orally Inhaled Drug Products: Similarities and Differences.
    Lu D; Lee SL; Lionberger RA; Choi S; Adams W; Caramenico HN; Chowdhury BA; Conner DP; Katial R; Limb S; Peters JR; Yu L; Seymour S; Li BV
    AAPS J; 2015 May; 17(3):546-57. PubMed ID: 25758352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An approach for widening the bioequivalence acceptance limits in the case of highly variable drugs.
    Boddy AW; Snikeris FC; Kringle RO; Wei GC; Oppermann JA; Midha KK
    Pharm Res; 1995 Dec; 12(12):1865-8. PubMed ID: 8786957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generic dry powder inhalers bioequivalence: Batch-to-batch variability insights.
    Salama R; Choi HJ; Almazi J; Traini D; Young P
    Drug Discov Today; 2022 Nov; 27(11):103350. PubMed ID: 36096359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance properties of the population bioequivalence approach for in vitro delivered dose for orally inhaled respiratory products.
    Morgan B; Strickland H
    AAPS J; 2014 Jan; 16(1):89-100. PubMed ID: 24249218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.